JUVE Comment

Prior to the UPC launching, this small mixed IP boutique was not a standout contender for an abundance of UPC cases. Indeed, in the court’s initial months it was barely present as its core client base among NPEs held back from filing lawsuits. However, this has changed significantly. Peterreins Schley is now one of the strongest outfits on the plaintiff side for mobile communications cases at the new court. Its most important clients at the UPC are NPE Daedalus Prime, Nera Innovations and Headwarter Research. It also filed two lawsuits against Nintendo on behalf of Malikie Innovations in autumn 2024. It is also representing Lionra Technologies in a lawsuit against Cisco over semiconductors.

The firm’s strong ties to NPEs ought to have signalled to competitors that the Munich outfit would be a strong rival, especially since Peterreins Schley has a proven UPC expert in Thomas Adam, who was closely involved in the new court’s creation. In summer 2022, the firm added Bird & Bird partner Marc Grunwald, who is now conducting healthcare-related UPC proceedings for Insulet and Visibly. In this respect, the firm has translated its second area of expertise in medical device manufacturing into UPC work. Peterreins Schley remains independent and has not yet worked with outfits in other UPC jurisdictions or the UK but does not rule out the possibility in the future.

Strengths

Litigation mostly for claimants over medical technology and mobile communications. The latter mainly for NPEs.

Recommended individuals

Thomas Adam, Marc Grunwald

Team

6 lawyers, 12 patent attorneys, 1 dual qualified

Clients

Daedalus Prime against Xiaomi und MediaTreck over mobile communications; Daedalus Prime against Xiaomi action over mobile communications; Headwater Research against Samsung Electronics over mobile communications; Malikie Innovations against Nintendo over mobile communications; Lionra Technologies against Cisco over semiconductors; Nera Innovations against Samsung electronics over mobile communications; Insulet against Menarini Diagnostic and EOFLow over insulin pumps; Visibly against Easee over online eye tests (all public knowledge).